Insider buying last 90 days
No open-market insider purchases were filed for FTRE in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every FTRE insider filing, plotted on the chart in Gekko.Open FTRE in Gekko
NASDAQ: FTRE
Fortrea (FTRE) Stock Analysis & Forecast
Oct 12 close
$21.00+0.16 (+0.8%)
Gekko Brief
AI summaryOct 12 closeFortrea shares climbed this week after the company exceeded quarterly expectations, reporting adjusted EPS of $0.23 on revenue of $678.2 million, prompting an upgrade from Wall Street Zen from hold to buy. Barclays also raised its price target to $23.00 from $22.00 while reiterating an Equal Weight rating, and the stock touched a new 52-week high of $21.99 before pulling back. Fortrea has also confirmed it will release third quarter 2026 results on 29 October, before the market opens.
Fortrea closed at $21.00, up 0.8%, sitting above both its 50-day average of $18.94 and 200-day average of $15.30, with the 50-day above the 200-day. The GekkoIndex reads 51.3, placing the stock in the Neutral zone. Price stands 6.7% above Gekko Fair Value of $19.68. Over the past six months the stock has returned 123.9%, and over the past year 95.3%, against a 52-week range of $8.55 to $23.51.
The next earnings date falls on 29 October, 16 days out and within a typical 20-trading-day holding window; the prior report produced a -7.8% reaction despite an EPS beat, and the average absolute move around results has been 16.1%. No insider, Congress or unusual options activity appears in the current windows. Seasonally, the next 20 trading days have averaged a 4.2% return over 3 years, rising in 2 of those periods. Analyst consensus across 11 firms stands at Hold, with a target of $20.83, implying a -0.8% consensus upside from current levels.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Fortrea price vs fair value
Close $21.00200-day averageGekko Fair Value $19.68
Fortrea quick facts
- Market cap
- $2.00B
- P/E ratio
- —
- Forward P/E
- 12.1
- EPS, TTM
- −$0.91
- Revenue, TTM
- $2.68B
- Profit margin
- -3.2%
- Dividend yield
- —
- Beta
- 1.91
- Volume
- 1.18M avg 1.65M
- 1-year return
- +95.3%
- Typical daily move
- ±5.4%
- Typical 20-day move
- ±12.3%
- 50-day average
- $18.94
- 200-day average
- $15.30
- Next earnings
- Oct 29 before open
- Shares outstanding
- 95.10M
Fortrea swing-trade checklist
Fortrea scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $21.00 is above the 50-day ($18.94) and 200-day ($15.30) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
51.3, Neutral
Reading 51.3 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
6.7% above
Price is 6.7% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 17 days
Reports on Oct 29, 2026, 17 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+4.2% on average
From this point in the calendar, the next 20 trading days averaged +4.2% over 3 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Fortrea stock chart and price history
Fortrea closed at $21.00 on Oct 12, 2026, +95.3% over the past year, inside a 52-week range of $8.55 to $23.51.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +22.1%
- 3 months
- +16.5%
- 6 months
- +123.9%
- 1 year
- +95.3%
The full FTRE chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open FTRE in Gekko
Follow Fortrea through every session
Put FTRE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track FTRE in GekkoFree for 7 days. No credit card required.
About Fortrea
Fortrea provides research and development support to companies working on new drugs and medical devices, operating as a contract research organization on a global scale. It is perhaps best recognized for guiding clinical trials through every stage, from early-phase pharmacology work to post-approval studies, serving biopharmaceutical and medical device makers that need outside expertise to run these programs.
The company splits its work into two areas. One handles clinical services, covering the full arc of trial development and pharmacology support. The other, enabling services, focuses on patient access programs and technology tools designed to manage randomization and keep trial medication supplies organized. Fortrea works with clients through several arrangements, including full-service contracts, functional service provider setups, and hybrid models, and its customers are mainly pharmaceutical, biotechnology, and medical device firms.
Fortrea was established in 2023 and is headquartered in Durham, North Carolina. Its shares are listed on the NASDAQ under the ticker FTRE.
- Listed
- NASDAQ
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Website
- fortrea.com
Fortrea GekkoIndex: the smart money zone
Fortrea’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.3, in the Neutral zone, up 1.7 points over five sessions.
51.3Neutral
Up 1.7 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 61 | −3.4% | −10.8% | ||
| Accumulation | 248 | 0.0% | −1.6% | ||
| Neutral (current zone) | 325 | +1.2% | +5.7% | ||
| Distribution | 43 | +0.6% | +3.1% | ||
| Selling | 5 | Too few readings yet | |||
Average FTRE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the FTRE price, zone by zone.Track FTRE in Gekko
Is Fortrea stock overvalued? Gekko Fair Value
Fortrea trades 6.7% above Gekko Fair Value of $19.68, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Fortrea shares are worth, recalculated every trading day.
$19.68
Gekko Fair Value, Oct 10, 2026
6.7% Overvalued
At the end of Aug 2026 the price was 6.8% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open FTRE in Gekko
Fortrea insider and Congress trading
No open-market insider purchases were filed for Fortrea, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in FTRE were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for FTRE, plotted on the chart in Gekko.Open FTRE in Gekko
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold FTRE.
0added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko
Fortrea earnings: next date and track record
Fortrea reports on Oct 29, 2026, before the open (17 days away), and beat the EPS estimate in 4 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected before the open, 17 days away
- EPS estimate
- $0.22
- Revenue estimate
- $671.6M
4 of 8reports beat the EPS estimate
±16.1%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 29, 2026 AI summary
- What they said
- Fortrea reported Q2 2026 results showing steady progress on commercial traction, operational delivery, and financial discipline. The company raised full-year revenue and adjusted EBITDA guidance. Biotech funding has strengthened and large pharma procurement has normalized. A notable leadership disruption occurred as new CFO Jason Madlock was sidelined due to a restrictive covenant dispute with his former employer, with board member David Smith serving as interim CFO.
- Guidance
- Management raised full-year revenue and adjusted EBITDA guidance following Q2 results. Improved market conditions, including stronger biotech funding and normalized large pharma procurement, support a cautiously optimistic outlook for continued growth and margin expansion.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $0.23 est $0.18 | $678.2M est $647.6M | −7.8% |
| May 5, 2026 | $0.16 est $0.03 | $636.5M est $628.5M | +27.7% |
| Feb 26, 2026 | $0.09 est $0.16 | $660.5M est $665.2M | +3.7% |
| Nov 5, 2025 | $0.12 est $0.16 | $701.3M est $665.2M | +13.6% |
| Aug 6, 2025 | $0.19 est $0.06 | $710.3M est $623.4M | +10.4% |
| May 12, 2025 | $0.02 est −$0.07 | $651.3M est $610.9M | −18.7% |
| Mar 3, 2025 | $0.18 est $0.36 | $697.0M est $661.0M | −20.9% |
| Nov 8, 2024 | $0.23 est $0.27 | $674.9M est $703.9M | +26.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Fortrea stock forecast and analyst price targets
Analysts’ average 12-month price target for Fortrea is $20.83, −0.8% from the last close, from 11 firms rating the stock in the last 90 days.
$20.83consensus 12-month target, −0.8% from the last close
Now $21.00Avg $20.83
Low $15.50High $25
Each firm’s latest rating in the last 90 days: 11 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 9 | Bank of America Securities | $15.50 | −26.2% |
| Oct 6 | Barclays | $23 | +9.5% |
| Oct 2 | UBS | $22 | +4.8% |
| Sep 30 | UBS | $22 | +4.8% |
| Sep 10 | William Blair | — | — |
+5.7%average 20-day move after past Neutral readings
+4.2%average move over the next 20 trading days in the last 3 years
±5.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Fortrea seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, Fortrea averaged +4.2% across the last 3 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.7% | 2 of 3 |
| Next 10 trading days | +4.2% | 1 of 3 |
| Next 15 trading days | −1.0% | 1 of 3 |
| Next 20 trading days | +4.2% | 2 of 3 |
| Next 30 trading days | +8.9% | 2 of 3 |
For scale, FTRE’s typical 20-trading-day move in either direction is about 12.3%.
Fortrea market cap and key statistics
Fortrea’s market cap is $2.00B and revenue of $2.68B over the last twelve months.
Valuation
- Market cap
- $2.00B
- Forward P/E
- 12.1
- EPS, TTM
- −$0.91
- Gekko Fair Value
- $19.68
Trading
- Volume
- 1.18M
- Avg volume, 20 days
- 1.65M
- 52-week high
- $23.51
- 52-week low
- $8.55
- Shares outstanding
- 95.10M
Financials
- Revenue, TTM
- $2.68B
- Profit margin
- -3.2%
- Return on equity
- -15.3%
- Quarterly earnings growth, YoY
- −57.4%
Risk and income
- Beta
- 1.91
- Typical daily move
- ±5.4%
- Typical 20-day move
- ±12.3%
Fortrea stock news this week
Coverage of Fortrea this week reads positive: 5 positive, 2 neutral and 0 negative headlines.
- Fortrea (NASDAQ:FTRE) Upgraded at Wall Street ZenMarketBeat, Oct 10
- MindWalk (NASDAQ:HYFT) & Fortrea (NASDAQ:FTRE) Head to Head ContrastDefense World, Oct 9
- Ausbil Investment Management Ltd Decreases Stake in Fortrea Holdings Inc. $FTREMarketBeat, Oct 8
- Fortrea Holdings Price Target Raised to $23.00/Share From $22.00 by BarclaysMoomoo, Oct 6
- Fortrea Holdings Inc stock hits 52-week high at 21.99 USDInvesting.com, Oct 6
- Why is Fortrea stock surging today?Investing.com, Oct 6
Fortrea peers
Fortrea’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SHOPShopify | Distribution | 25.9% above |
| CTASCintas | Neutral | 14.1% above |
| PYPLPayPal | Neutral | 0.8% below |
| XYZBlock | Neutral | 7.5% above |
| CPAYCorpay | Neutral | 17.5% below |
| FISVFiserv | Accumulation | 39.7% below |
A peer links to its own page where one exists.
Fortrea stock FAQ
What is Fortrea’s market cap?
Fortrea’s market cap is $2.00B at the Oct 12, 2026 close of $21.00, with 95.10M shares outstanding.
What is the Fortrea stock forecast?
The consensus analyst 12-month price target for Fortrea is $20.83, −0.8% from the last close. Of the 11 firms that rated the stock in the last 90 days, 6 rate it a buy, 4 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Fortrea stock overvalued or undervalued?
On Gekko’s estimate Fortrea is overvalued: the Oct 12, 2026 close of $21.00 is 6.7% above Gekko Fair Value of $19.68. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Fortrea report earnings next?
Fortrea is expected to report on Oct 29, 2026, before the market opens (17 days away). Analysts expect earnings of $0.22 per share on revenue of $671.6M. Fortrea beat the earnings estimate in 4 of its last 8 reports, moving 16.1% on average across the report.
What is Fortrea’s 52-week high and low?
Fortrea’s 52-week high is $23.51 and its 52-week low is $8.55; it closed at $21.00 on Oct 12, 2026, +95.3% over the past year. Over the last five years the shares peaked at $41.02 on Mar 21, 2024.
Is Fortrea stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Fortrea the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.